Open AccessA ‘tailor made’ vaccine trialled as part of public health response to group B meningococcal epidemic in New Zealand
Author(s) -
Johan Holst,
Ingeborg S. Aaberge,
Philipp Oster,
Diana Len,
Diana Martin,
Jane O’Hallahan,
K Nord,
Hanne Nøkleby,
Lisbeth Meyer Næss,
Paul A. Kristiansen,
A G Skryten,
Klaus Bryn,
Audun Aase,
Rino Rappuoli,
E Rosenqvist
Publication year - 2003
Language(s) - English
Resource type - Journals
ISSN - 9999-1233
DOI - 10.2807/esw.07.30.02262-en
Subject(s) - meningococcal vaccine , meningococcal disease , public health , medicine , meningococcal infections , group b , neisseria meningitidis , virology , family medicine , immunology , biology , immunization , nursing , antigen , bacteria , genetics
New Zealand has experienced an epidemic of serogroup B meningococcal infection since 1991